This is a synthetic peptide designed for use in combination with anti-FOXO4 antibody (Catalog #: AVARP01018_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FOXO4
Reaktivität: Human, Maus, Affe
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
FOXO4
(Forkhead Box O4 (FOXO4))
Hintergrund
FOXO4 is transcription factor involved in the regulation of the insulin signaling pathway. It binds to insulin-response elements (IREs) and can activate transcription of IGFBP1. The protein can down-regulate expression of HIF1A and suppress hypoxia-induced transcriptional activation of HIF1A-modulated genes. It is also involved in negative regulation of the cell cycle. A chromosomal aberration involving FOXO4 is found in acute leukemias.
Alias Symbols: AFX, AFX1, MGC120490, MLLT7
Protein Interaction Partner: AKT1,CCND1,CDKN1A,CTNNB1,FOXG1,SMAD3,SMAD4,AKT1,AKT2,CREBBP,CTNNB1,ESR1,FOXG1,SMAD3,SMAD4,XPO1,YWHAZ,CREBBP,ESR1,MDM2,PIN1,SMAD3,SMAD4,UBC,USP7,XPO1